Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Rapoport

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Headache|October 1, 2009
Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studiesCecilia Hedlund, Alan M Rapoport, David W Dodick, et al.
Headache|June 8, 2018
DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled StudyRichard B Lipton, Sagar Munjal, Elimor Brand-Schieber, et al.
CNS Drugs|March 17, 2019
DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with TreatmentRichard B Lipton, Sagar Munjal, Elimor Brand-Schieber, et al.
CNS Drugs|July 24, 2004
Intranasal medications for the treatment of migraine and cluster headacheAlan M Rapoport, Marcelo E Bigal, Stewart J Tepper, et al.
Arquivos De Neuro-Psiquiatria|October 5, 2002
Hemicrania continua: a report of ten new casesMarcelo E Bigal, Stewart J Tepper, Fred D Sheftell, et al.
Headache|February 9, 2016
Indomethacin Responsive Headaches: Exhaustive Systematic Review with Pooled Analysis and Critical Appraisal of 81 Published Clinical StudiesEmilia C Bordini, Carlos A Bordini, Yohannes W Woldeamanuel, et al.
Revista Do Hospital Das Clinicas|March 4, 2003
New migraine preventive options: an update with pathophysiological considerationsMarcelo E Bigal, Alan M Rapoport, Fred D Sheftell, et al.
CNS Drugs|April 17, 2003
The triptan formulations : how to match patients and productsAlan M Rapoport, Stewart J Tepper, Marcelo E Bigal, et al.
CNS Drugs|December 8, 2004
Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tabletEgilius L H Spierings, Alan M Rapoport, David W Dodick, et al.
Headache|December 6, 2005
Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot studyFred D Sheftell, Alan M Rapoport, Stewart J Tepper, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Headache|October 1, 2009
Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studiesCecilia Hedlund, Alan M Rapoport, David W Dodick, et al.
Headache|June 8, 2018
DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled StudyRichard B Lipton, Sagar Munjal, Elimor Brand-Schieber, et al.
CNS Drugs|March 17, 2019
DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with TreatmentRichard B Lipton, Sagar Munjal, Elimor Brand-Schieber, et al.
CNS Drugs|July 24, 2004
Intranasal medications for the treatment of migraine and cluster headacheAlan M Rapoport, Marcelo E Bigal, Stewart J Tepper, et al.
Arquivos De Neuro-Psiquiatria|October 5, 2002
Hemicrania continua: a report of ten new casesMarcelo E Bigal, Stewart J Tepper, Fred D Sheftell, et al.
Headache|February 9, 2016
Indomethacin Responsive Headaches: Exhaustive Systematic Review with Pooled Analysis and Critical Appraisal of 81 Published Clinical StudiesEmilia C Bordini, Carlos A Bordini, Yohannes W Woldeamanuel, et al.
Revista Do Hospital Das Clinicas|March 4, 2003
New migraine preventive options: an update with pathophysiological considerationsMarcelo E Bigal, Alan M Rapoport, Fred D Sheftell, et al.
CNS Drugs|April 17, 2003
The triptan formulations : how to match patients and productsAlan M Rapoport, Stewart J Tepper, Marcelo E Bigal, et al.
CNS Drugs|December 8, 2004
Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tabletEgilius L H Spierings, Alan M Rapoport, David W Dodick, et al.
Headache|December 6, 2005
Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot studyFred D Sheftell, Alan M Rapoport, Stewart J Tepper, et al.
Pageof 12